These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15451788)

  • 21. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.
    Bell RM; Yellon DM
    J Am Coll Cardiol; 2003 Feb; 41(3):508-15. PubMed ID: 12575984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-ischemic cardioprotection by A2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway.
    Boucher M; Pesant S; Falcao S; de Montigny C; Schampaert E; Cardinal R; Rousseau G
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):416-22. PubMed ID: 15076226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury.
    Cai Z; Semenza GL
    Circulation; 2004 May; 109(17):2050-3. PubMed ID: 15117842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Through the looking glass: a positive inotropic drug and ischemic preconditioning.
    Vander Heide RS; Marsh JD
    Circulation; 1997 Apr; 95(8):1989-91. PubMed ID: 9133503
    [No Abstract]   [Full Text] [Related]  

  • 25. Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions.
    Ye Y; Perez-Polo JR; Birnbaum Y
    Ann N Y Acad Sci; 2010 Oct; 1207():76-82. PubMed ID: 20955429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity.
    Minamino T; Kitakaze M; Morioka T; Node K; Komamura K; Takeda H; Inoue M; Hori M; Kamada T
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H238-44. PubMed ID: 8769757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling.
    Hanlon PR; Fu P; Wright GL; Steenbergen C; Arcasoy MO; Murphy E
    FASEB J; 2005 Aug; 19(10):1323-5. PubMed ID: 15946993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
    Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
    Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of intracellular Ca2+ in activation of protein kinase C during ischemic preconditioning.
    Node K; Kitakaze M; Sato H; Minamino T; Komamura K; Shinozaki Y; Mori H; Hori M
    Circulation; 1997 Aug; 96(4):1257-65. PubMed ID: 9286957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.
    Eckle T; Krahn T; Grenz A; Köhler D; Mittelbronn M; Ledent C; Jacobson MA; Osswald H; Thompson LF; Unertl K; Eltzschig HK
    Circulation; 2007 Mar; 115(12):1581-90. PubMed ID: 17353435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.
    Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K
    Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
    Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.
    Simpkin JC; Yellon DM; Davidson SM; Lim SY; Wynne AM; Smith CC
    Basic Res Cardiol; 2007 Nov; 102(6):518-28. PubMed ID: 17694254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts.
    Takahama H; Minamino T; Hirata A; Ogai A; Asanuma H; Fujita M; Wakeno M; Tsukamoto O; Okada K; Komamura K; Takashima S; Shinozaki Y; Mori H; Mochizuki N; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Jun; 20(3):159-65. PubMed ID: 16775664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
    Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
    Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.
    Kristo G; Yoshimura Y; Ferraris SP; Jahania SA; Mentzer RM; Lasley RD
    J Am Coll Surg; 2004 Oct; 199(4):586-94. PubMed ID: 15454144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.
    Birnbaum Y; Birnbaum GD; Birnbaum I; Nylander S; Ye Y
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):539-550. PubMed ID: 27830382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.